ZIVO
ZIVO Bioscience, Inc.
OTC Markets OTCIDUSDEQUITY
Healthcare
DELAYED
Last price
4.25
▲ 0.30 (7.59%)
MARKET · —
Price
Open
4.25
Prev close
3.95
Day high
4.25
Day low
4.25
Volume
100
Market cap
$17.91M
P/E (TTM)
—
52W range
1.11 – 19.01
Trailing performance
Returnvs SPY
1W
-0.93%
+0.4%
1M
-15.00%
-18.7%
3M
+4.68%
+1.6%
6M
-57.50%
-68.6%
YTD
-51.15%
-63.4%
1Y
-75.29%
-95.3%
3Y
-61.08%
-135.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$17.91M
Enterprise value$17.29M
Revenue (TTM)$209.03K
Gross profit$66.21K
EBITDA—
Net income$-8.49M
EPS (TTM)$-2.03
Free cash flow$-2.62M
Total cash$57.22K
Total debt$819.70K
Book value / share$-0.86
Shares outstanding4.22M
Float1.47M
Short % of float2.61%
Dividend yield—
Beta (5Y)0.18
Valuation & profitability ratios
Trailing P/E—
Forward P/E-3.54
PEG ratio—
Price / sales—
Price / book—
EV / revenue82.71
EV / EBITDA—
Gross margin31.67%
Operating margin-1551.76%
Profit margin0.00%
Return on equity—
Return on assets-1001.91%
Debt / equity—
Current ratio0.08
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Total revenue | $157.22K | $27.65K | $0 | $0 |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 |
| R&D | — | — | — | — |
| SG&A | — | — | — | — |
| Operating income | — | — | — | — |
| Pre-tax income | — | — | — | — |
| Tax provision | $0 | $0 | $0 | $0 |
| Net income | -$13.38M | -$7.78M | -$8.75M | $0 |
| EBIT | $0 | $0 | $0 | $0 |
| Line item | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Cash & equivalents | — | — | — | — |
| Short-term investments | — | — | — | — |
| Net receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Total current assets | — | — | — | — |
| Total assets | — | — | — | — |
| Total current liabilities | — | — | — | — |
| Long-term debt | — | — | — | — |
| Total liabilities | — | — | — | — |
| Retained earnings | — | — | — | — |
| Shareholder equity | — | — | — | — |
| Line item | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Net income | -$13.38M | -$7.78M | -$8.75M | $0 |
| Depreciation | — | — | — | — |
| Change in working capital | — | — | — | — |
| Operating cash flow | — | — | — | — |
| Capital expenditure | — | — | — | — |
| Investing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Buybacks | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Net change in cash | — | — | — | — |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Sep 2025 | -0.36 | -0.27 | +25.0% |
| Jun 2025 | -0.41 | -0.43 | -4.9% |
| Mar 2025 | -0.52 | -1.12 | -115.4% |
| Dec 2024 | -0.56 | -0.36 | +35.7% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $0 | — |
| Next year | — | — | $0 | — |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders47.30%
Held by institutions0.10%
Institutions holding1
Price targets, consensus spread, insider and institutional ownership.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
1.84M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Apr 17, 26 | STROME MARK E. Beneficial Owner of more than 10% of a Class of Security |
BUY | 100.00K | $200.00K | Indirect |
| Feb 27, 26 | YALDOO LAITH L Director and Beneficial Owner of more than 10% of a Class of Security |
BUY | 1.54K | $15.00K | Indirect |
| Feb 12, 26 | STROME MARK E. Beneficial Owner of more than 10% of a Class of Security |
BUY | 20.00K | $195.40K | Indirect |
| Feb 10, 26 | YALDOO LAITH L Director and Beneficial Owner of more than 10% of a Class of Security |
BUY | 2.43K | $25.00K | Indirect |
| Jan 26, 26 | CORNELL ALISON A Director |
BUY | 11.71K | $100.00K | Direct |
| Jan 26, 26 | PAYNE JOHN BERNARD Chief Executive Officer |
BUY | 11.71K | $100.00K | Direct |
| Jan 14, 26 | MAGGIORE CHRISTOPHER D Director and Beneficial Owner of more than 10% of a Class of Security |
BUY | 1.77K | $14.99K | Direct |
| Jan 14, 26 | YALDOO LAITH L Director and Beneficial Owner of more than 10% of a Class of Security |
BUY | 1.77K | $14.99K | Indirect |
| Nov 28, 25 | YALDOO LAITH L Director and Beneficial Owner of more than 10% of a Class of Security |
BUY | 2.78K | $24.99K | Indirect |
| Oct 13, 25 | STROME MARK E. Beneficial Owner of more than 10% of a Class of Security |
BUY | 20.26K | $250.00K | Indirect |
| Oct 10, 25 | YALDOO LAITH L Director and Beneficial Owner of more than 10% of a Class of Security |
BUY | 1.66K | $19.99K | Indirect |
| Oct 8, 25 | MAGGIORE CHRISTOPHER D Director and Beneficial Owner of more than 10% of a Class of Security |
BUY | 23.68K | $284.42K | Direct |
| Sep 30, 25 | YALDOO LAITH L Director and Beneficial Owner of more than 10% of a Class of Security |
BUY | 15.32K | $245.00K | Indirect |
| Jun 13, 25 | YALDOO LAITH L Director and Beneficial Owner of more than 10% of a Class of Security |
BUY | 3.49K | $49.98K | Indirect |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
CORNELL ALISON A |
Director | 279.48K | Purchase |
MAGGIORE CHRISTOPHER D |
Director and Beneficial Owner of more than 10% of a Class of Security | 519.29K | Purchase |
MASTERSON NOLA E |
Director | 130.91K | Stock Award(Grant) |
PAYNE JOHN BERNARD |
Chief Executive Officer | 19.62K | Purchase |
STROME MARK E. |
Beneficial Owner of more than 10% of a Class of Security | — | Purchase |
YALDOO LAITH L |
Director and Beneficial Owner of more than 10% of a Class of Security | — | Purchase |
Moving averages & technicals
SMA 10
4.14
+2.58% from price
SMA 20
4.12
+3.07% from price
SMA 50
4.25
+0.10% from price
SMA 100
3.83
+11.10% from price
SMA 200
6.70
-36.57% from price
EMA 12
4.12
+3.06% from price
EMA 26
4.18
+1.71% from price
EMA 50
4.24
+0.27% from price
RSI (14)
52.0
Neutral
MACD (12,26,9)
-0.05
Hist -0.00
ATR (14)
0.07
1.65% of price
Realised vol 30D
114.7%
Annualised
Bollinger upper
4.59
20, 2σ
Bollinger lower
3.65
20, 2σ
50 / 200 cross
Death
4.25 vs 6.70
Trend bias
Below 200
-36.57%
Risk profile
Beta vs SPY
0.46
Less volatile than market
Correlation to SPY
0.03
Largely independent
Realised vol 30D
114.7%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-93.8%
Peak to trough
Max drawdown 5Y
-98.5%
Peak to trough
ATR 14
0.07
1.65% of price
Beta (reported)
0.18
5Y monthly, from filing
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.